ReleaseWire Connect

RASP is a security technology that enables real-time application protection by identifying and blocking any malicious attacks.

The global microwavable foods market was valued at $100,098 million in 2016, and is projected to reach $136,305 million by 2023, registering a CAGR of 4.4% from 2017 to 2023. Microwavable food is defined as a prepackaged meal or food product that requires minimal preparation for cooking. Shelf stable microwavable food, chilled food, and frozen food are categorized under products that can be prepared in a microwave. Microwaves cause water, fat, and sugar molecules to vibrate 2.5 million times per second, producing heat that cooks the food. Foods that can be safely stored at room temperature or "on the shelf" are called shelf stable microwavable foods. These foods are pretreated by heat or dried to destroy food-borne microorganisms. Microwavable chilled food is stored at refrigeration temperatures, i.e., at or below 0 to ?5°C. Chilled food products have high quality and are microbiologically safe at the point of consumption, although they have a low shelf life. Microwavable frozen food is preferred over microwavable chilled food, as it can be stored for longer periods and can be prepared in less time. Freezing maintains the nutritional value of the food items and also increases their shelf life. Microwavable frozen products do not require any added preservatives because microorganisms are unable to grow when the temperature of the food is below ?9.5°C.

Blockchain is a new technology, based on distributed ledger technology. In blockchain technology, ledgers securely record information across a group of networks.

The global systems training market for the corporate sector involves training programs on the design, development, deployment, and maintenance of systems (hardware and software) used in business processes.

The global gene therapy market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. Gene therapy is a technique that involves the delivery of nucleic acid polymers into a patients cells as a drug to treat diseases. It fixes a genetic problem at its source. The process involves modifying the protein either to change the genetic expression or to correct a mutation. The emergence of this technology meets the rise in needs for better diagnostics and targeted therapy tools. For instance, genetic engineering can be used to modify physical appearance, metabolism, physical capabilities, and mental abilities such as memory and intelligence. In addition, it is also used for infertility treatment. Gene therapy offers a ray of hope for patients, who either have no treatment options or show no benefits with drugs currently available. The ongoing success has strongly supported upcoming researches and has carved ways for enhancement of gene therapy.

The global urinary incontinence devices market was valued at $1,611 million in 2016, and is expected to reach $3,411 million by 2023, registering a CAGR of 11.3% during the forecast period. Urinary incontinence devices aid in collecting and holding urine; such devices help manage urinary incontinence effectively. Patients suffer from urine leakage that cannot be controlled. If the condition is severe, the patient is recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

A contact center acts as a central point in an enterprise from where all contacts are managed. It plays a prominent role in the broad customer management strategies of an enterprise.

An ePedigree software records the change of custody of a drug by a manufacturer, repackager, or wholesaler, along with the final sale to a pharmacy or any other dispenser. It secures the supply chain by providing a systemic drug tracking platform and evaluating any discrepancies in the supply chain.

Telemedicine refers to the provision of healthcare services from a significant distance from the patient's location. It is the use of information technology, including hardware, software, telecom, and IT services to render healthcare services from a distance or a remote location. It comprises clinical health services that include: teleconsultation, telemonitoring, tele-education, telecare, and tele-surgery. Telemedicine contributes significantly to the IT spending by the healthcare industry.

The Europe histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.